Free. Unsubscribe any time.
GYRE THERAPEUTICS, INC. (GYRE)
GYRE THERAPEUTICS, INC. filed 33 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 2 reporting owners, covering 71 transactions and 122,698 shares. 33 carry the SEC's AFF10B5ONE flag; 0 name a plan only in a footnote. No results print is on file in this window, so no interval is measured.
What stands out
- The most recent filing on file, dated 2026-05-07, came 343 days after the one before it (2025-05-29) and reports 2 transactions against 2 in the filing before it.
- The sales it reports total 10,315 shares, 7,757 more than the 2,558 in the filing before it.
- Its 33 filings on file run from 2025-01-02 to 2026-05-07, and state 2 plan adoption dates, from 2024-09-13 to 2025-03-13.
Trades in GYRE THERAPEUTICS, INC. 71
- Ma Songjiang — 2024-01-03 · S · 833 shares
- Ma Songjiang — 2024-12-30 · S · 2,000 shares
- Ma Songjiang — 2024-12-31 · S · 2,000 shares
- Ma Songjiang — 2025-01-02 · S · 2,000 shares
- Ma Songjiang — 2025-01-03 · S · 1,167 shares
- Ma Songjiang — 2025-01-06 · S · 941 shares
- Ma Songjiang — 2025-01-07 · S · 1,275 shares
- Ma Songjiang — 2025-01-10 · S · 1,057 shares
- Ma Songjiang — 2025-01-13 · S · 56 shares
- Ma Songjiang — 2025-01-14 · S · 2,000 shares
- Ma Songjiang — 2025-01-15 · S · 2,000 shares
- Ma Songjiang — 2025-01-16 · S · 2,000 shares
Adoption dates in GYRE THERAPEUTICS, INC. 2
- 2024-09-13 — stated in 32 filings
- 2025-03-13 — stated in 1 filing
Results prints in GYRE THERAPEUTICS, INC. 0
Trades before a print in GYRE THERAPEUTICS, INC. 0
Interval to GYRE THERAPEUTICS, INC.’s next reported results date
How the interval and sources are counted →
- 0within 5 days
- 0within 10 days
- —shortest, days
- 71no later print
Adoption dates GYRE THERAPEUTICS, INC. states
- 2024-09-13 in 32 filings
- 2025-03-13 in 1 filing
Filing text: “10b5-1 trading plan adopted on September 13, 2024”
Sources: SEC EDGAR full-text search and the SEC submissions API.